<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ayesha Shah, MBBS, FRACP, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gerald Holtmann, MD, PhD, MBA, FRACP, FRCP, FAHMS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 01, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Small intestinal bacterial overgrowth (SIBO) is a dysbiosis in which the small bowel is colonized by an excessive number and/or abnormal type of aerobic and anaerobic microbes that are usually found in the colon. </p><p>This topic will review the etiology, pathogenesis, clinical manifestations, and diagnosis of SIBO. The management of SIBO is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4783.html" rel="external">"Small intestinal bacterial overgrowth: Etiology and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/4778.html" rel="external">"Small intestinal bacterial overgrowth: Management"</a>.)</p><p class="headingAnchor" id="H281085201"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The population-based prevalence of SIBO is unclear. The incidence of SIBO increases with age. </p><p class="headingAnchor" id="H2633272856"><span class="h1">ETIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>Several disorders predispose to SIBO by altering mucosal defenses  (<a class="graphic graphic_table graphicRef81285" href="/d/graphic/81285.html" rel="external">table 1</a>) [<a href="#rid1">1-3</a>]. Patients may have more than one predisposing cause. As an example, the high prevalence of SIBO in older adults may be due to small intestinal dysmotility and gastric hypochlorhydria.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Motility disorders </strong>– The migrating motor complex (MMC) and, in particular, phase III of the MMC clears the small bowel of debris [<a href="#rid4">4</a>]. A lack of interdigestive phase III activity in patients with irritable bowel syndrome, narcotic use, intestinal pseudo-obstruction, and diabetes predisposes them to SIBO. Small bowel motility is also affected in acute or chronic radiation enteritis, amyloidosis, and scleroderma [<a href="#rid5">5-9</a>]. (See  <a class="medical medical_review" href="/d/html/2629.html" rel="external">"Pathophysiology of irritable bowel syndrome", section on 'Bacterial overgrowth'</a> and  <a class="medical medical_review" href="/d/html/7548.html" rel="external">"Gastrointestinal manifestations of systemic sclerosis (scleroderma)", section on 'Small intestinal involvement'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomic disorders</strong> – Adhesions or strictures, small intestinal diverticulosis, blind intestinal loops, and reversed segment can predispose to SIBO due to intestinal stasis [<a href="#rid10">10</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immune disorders</strong> – Immunoglobulins in intestinal secretions are important in maintaining the microbial homeostasis [<a href="#rid11">11</a>]. Patients with common variable immunodeficiency, IgA deficiency, and acquired immunodeficiency (eg, HIV) are therefore at increased risk of SIBO. (See  <a class="medical medical_review" href="/d/html/99315.html" rel="external">"Gastrointestinal manifestations in primary immunodeficiency"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastric hypochlorhydria</strong> – Hypochlorhydria either from long-term use of a proton pump inhibitor or autoimmune etiology (chronic atrophic gastritis), is an important co-factor in the development of SIBO when present independently or in combination with other predisposing factors. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic and systemic disorders</strong> – Disorders such as pancreatic insufficiency and chronic liver disease can predispose to SIBO by changing the quantity and composition of digestive enzymes or bile. (See  <a class="medical medical_review" href="/d/html/2643.html" rel="external">"Diabetic autonomic neuropathy of the gastrointestinal tract", section on 'Diabetic diarrhea'</a>.)</p><p></p><p class="headingAnchor" id="H3471999398"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>SIBO is usually associated with abnormally high counts of multiple organisms in the small intestine. Data suggests that in traditional SIBO, the most common organisms are <em>Escherichia coli</em> and <em>Klebsiella </em>[<a href="#rid7">7,12</a>]. Inflammation is caused by invasive strains of bacteria [<a href="#rid11">11</a>]. Facultative anaerobes can injure the intestinal surface by direct adherence and production of enterotoxins. Aerobic bacteria produce enzymes and metabolic products that can induce epithelial cell injury [<a href="#rid13">13</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intestinal effects</strong> – In its extreme form (usually associated with conditions such as blind loop syndrome) SIBO can cause maldigestion in the intestinal lumen or malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage (eg, tropical sprue). Bacterial overgrowth can also alter small bowel motility [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Carbohydrate malabsorption </strong>– Intraluminal degradation of carbohydrates leads to the production of short-chain fatty acids (butyrate, propionate, acetate, lactate) as well as carbon dioxide, hydrogen, hydrogen sulfide, and methane. Enterocyte damage due to bile acids and bacteria results in diarrhea due to reduction in enterocyte disaccharidase activity and transport of monosaccharides [<a href="#rid15">15</a>]. Fermentation of unabsorbed carbohydrates results in bloating, distension, and flatulence.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fat malabsorption</strong> – Fat malabsorption can lead to steatorrhea, weight loss, and deficiencies of fat-soluble vitamins (eg, vitamin A and D). SIBO results in deconjugation of primary bile acids, which can further worsen steatorrhea [<a href="#rid16">16,17</a>]. At physiologic pH, bile acids are fully ionized, preventing their absorption in the proximal small intestine and permitting sufficient concentrations for solubilization of dietary fat. However, deconjugated bile salts are reabsorbed by the jejunum, which may lead to fat malabsorption due to depletion of the normal bile acid pool. Bacterial deconjugation also leads to the production of lithocholic acid, which may be toxic to intestinal epithelium, resulting in impaired absorption of fat and other nutrients. Hydroxylated fatty acids (and free bile acids) also stimulate the secretion of water and electrolytes, leading to diarrhea. (See <a class="local">'Clinical features'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Protein malabsorption </strong>– Protein malabsorption results from damage to the epithelial barrier, resulting in increased intestinal permeability, decreased mucosal uptake of amino acids, and the intraluminal degradation of protein precursors by bacteria [<a href="#rid18">18</a>]. SIBO can also result in a reversible form of protein-losing enteropathy [<a href="#rid19">19</a>]. (See  <a class="medical medical_review" href="/d/html/4769.html" rel="external">"Protein-losing gastroenteropathy"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Vitamin deficiency and excess </strong>– Vitamin B12 deficiency in SIBO results from several different mechanisms. Although enteric bacteria synthesize cobalamin, they also successfully compete with the host for its absorption. In patients with severe SIBO, malabsorption of vitamin B12 results from mucosal damage to the ileal binding site. Only anaerobes can utilize vitamin B12 coupled to intrinsic factor. Thiamine and nicotinamide deficiency also result from bacterial utilization. </p><p></p><p class="bulletIndent2">In contrast, folate and vitamin K levels are elevated in SIBO due to bacterial synthesis. Increased intestinal permeability also contributes to increased vitamin K levels. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic effects</strong> – Production of toxins and increased intestinal permeability in SIBO have been associated with systemic complications. D-lactic acidosis is a rare neurologic syndrome in patients with SIBO associated with short bowel syndrome or a prior jejunoileal bypass. It is characterized by altered mental status ranging from confusion to coma, slurred speech, seizures, and ataxia resulting from bacterial fermentation of unabsorbed carbohydrates [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/2303.html" rel="external">"D-lactic acidosis", section on 'Pathogenesis'</a> and <a class="local">'Clinical features'</a> below.)</p><p></p><p class="bulletIndent1">Bacterial overgrowth has also been implicated in the pathogenesis of complications of chronic liver disease such as hepatic encephalopathy, nonalcoholic fatty liver disease, and irritable bowel syndrome. (See  <a class="medical medical_review" href="/d/html/3596.html" rel="external">"Pathogenesis of nonalcoholic fatty liver disease", section on 'Intestinal microbes'</a> and  <a class="medical medical_review" href="/d/html/1257.html" rel="external">"Hepatic encephalopathy: Pathogenesis", section on 'Bacterial overgrowth'</a>.) </p><p></p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H3413024795"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>The majority of patients with SIBO present with bloating [<a href="#rid21">21</a>]. Other common symptoms include flatulence, abdominal discomfort, or chronic watery diarrhea. It is important to remember that traditional SIBO was associated with post-surgical anatomy such as blind loop syndrome. However, it is increasingly recognized that SIBO is a potential cause of irritable bowel syndrome (IBS), functional dyspepsia, gastroparesis, chronic pancreatitis, etc [<a href="#rid22">22</a>] and, in these cases, malabsorption is less common.</p><p>Steatorrhea with greasy or bulky stools is rare and usually occurs in patients with SIBO and altered anatomy (eg, blind loop syndrome) [<a href="#rid23">23</a>]. Children can present with failure to gain weight [<a href="#rid24">24,25</a>]. In severe cases, patients have weight loss due to diarrhea or poor oral intake. </p><p>Patients with severe SIBO in the setting of a jejunoileal bypass surgery or short bowel syndrome (SBS) may have symptoms due to associated vitamin deficiency. Patients with vitamin B12 deficiency can present with weakness, sensory ataxia, and paresthesias. Patients with tetany due to hypocalcemia can present with perioral numbness, paresthesias of the hands and feet, and muscle cramps. Children may also have metabolic bone disease due to vitamin D deficiency. In rare cases, patients with SIBO and SBS present with altered mental status due to D-lactic acidosis after a high carbohydrate meal. Symptoms can range from confusion to coma, slurred speech, seizures, and ataxia [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/4775.html" rel="external">"Chronic complications of the short bowel syndrome in adults", section on 'Electrolyte and micronutrient deficiencies'</a> and  <a class="medical medical_review" href="/d/html/2303.html" rel="external">"D-lactic acidosis"</a>.)</p><p>Physical examination is usually normal in patients with SIBO. However, in some cases, the abdomen may be distended with an identifiable succussion splash due to fluid-filled loops of bowel, which may be palpable [<a href="#rid26">26</a>]. Patients with hypoalbuminemia due to malabsorption can have peripheral edema, however, this is rare. (See  <a class="medical medical_review" href="/d/html/4770.html" rel="external">"Pathophysiology of short bowel syndrome", section on 'The microbiome of SBS and pathophysiology of bacterial overgrowth'</a> and  <a class="medical medical_review" href="/d/html/2303.html" rel="external">"D-lactic acidosis"</a>.)</p><p class="headingAnchor" id="H114230270"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>Laboratory abnormalities are rarely seen and are usually associated with severe bacterial overgrowth or when SIBO occurs in association with an underlying anatomic abnormality [<a href="#rid21">21</a>]. Laboratory findings including macrocytic anemia, B12 deficiency, and the presence of fecal fat. Patients may also have low levels of thiamine and niacin and elevated serum folate and vitamin K levels [<a href="#rid27">27</a>]. In rare cases, microcytic anemia results from bleeding due to ulcers in stagnant intestinal loops [<a href="#rid28">28</a>]. Patients with protein losing enteropathy due to SIBO have hypoalbuminemia. (See <a class="local">'Pathogenesis'</a> above and  <a class="medical medical_review" href="/d/html/4769.html" rel="external">"Protein-losing gastroenteropathy", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H19806109"><span class="h2">Endoscopy findings</span><span class="headingEndMark"> — </span>The endoscopic appearance and histopathology of the small intestine and colon is normal in most patients with SIBO. Endoscopic findings of enteritis associated with severe SIBO may include mucosal edema, loss of normal vascular pattern, patchy erythema, friability, and in rare cases, ulceration [<a href="#rid26">26,29</a>]. Non-specific histopathological findings in patients with SIBO include villous blunting, cryptitis, intraepithelial lymphocytosis, and eosinophilia [<a href="#rid30">30</a>]. </p><p class="headingAnchor" id="H37681834"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H2367860522"><span class="h2">Approach to evaluation</span><span class="headingEndMark"> — </span>The diagnosis of SIBO should be suspected in patients with bloating, flatulence, abdominal discomfort, or chronic diarrhea. The diagnosis is established with a positive carbohydrate breath test or a bacterial concentration of &gt;10<sup>3</sup> colony forming units/mL in a duodenal aspirate culture. We perform a carbohydrate breath test to diagnose SIBO and measure hydrogen and methane gases in exhaled breath samples as it is simple and non-invasive [<a href="#rid31">31</a>]. Due to the limitations of culture (contamination and the invasive nature of culture), breath testing is the most practical alternative [<a href="#rid32">32</a>].</p><p>No additional evaluation is needed to diagnose SIBO. However, we obtain additional tests to diagnose laboratory abnormalities associated with SIBO and to rule out other causes of similar symptoms (eg, celiac disease, Crohn disease), which may co-exist with SIBO on a case-by-case basis. In patients with severe diarrhea or iron deficiency anemia, we perform endoscopic evaluation with colonoscopy and, if indicated, an upper endoscopy with small bowel biopsy. The evaluation of patients with chronic diarrhea is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings", section on 'Initial evaluation'</a>.)</p><p class="headingAnchor" id="H3664634802"><span class="h2">Carbohydrate breath test</span><span class="headingEndMark"> — </span>Breath tests are based on the principle that human cells cannot produce hydrogen and methane gases. Therefore, if these gases can be detected in breath samples, it indicates that there might be another source, such as the fermentation of carbohydrate substrate (eg, <a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">lactulose</a> or glucose) by microbes in the gut. These gases are then absorbed into the bloodstream and expired through the lungs. This principle has resulted in the development of multiple breath tests based on carbohydrate substrates. The carbohydrates that have traditionally been used as substances in breath testing for SIBO are glucose and lactulose. Each substrate possesses distinctive characteristics.</p><p><a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">Lactulose</a> is a nonabsorbable substance that is normally metabolized by gut bacteria in the colon with the production of hydrogen, hydrogen sulfide, and/or methane. In individuals without SIBO, the administration of lactulose results in a single peak in breath hydrogen within two to three hours due to the metabolism of lactulose by colonic flora. In patients with SIBO, administration of lactulose results in an early peak in breath hydrogen and/or methane levels due to metabolism by small bowel bacteria.</p><p>In addition to hydrogen and methane, gut bacteria also produce hydrogen sulfide (H<sub>2</sub>S). A cutoff value for the diagnosis of SIBO using H<sub>2</sub>S gas requires validation and determination of its clinical utility. </p><p>Glucose is rapidly absorbed from the proximal small bowel. When used as a substrate in the presence of SIBO, it is metabolized to hydrogen and/or methane in the small bowel lumen prior to absorption. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient preparation and test protocol</strong> – There is considerable variability in test methodology and interpretation of carbohydrate breath tests. Our recommendations are consistent with a 2017 North American consensus statement on hydrogen and methane-based breath testing in gastrointestinal disorders [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Antibiotics should be avoided four weeks prior to testing.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prokinetic drugs and laxatives should be held for one week prior to testing. Faster intestinal transit can lead to earlier delivery of the substrate to the colon and lead to false-positive test results.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complex carbohydrates (eg, bread, pasta, fiber) and dairy should be avoided for 12 hours prior to testing. Fermentable foods can cause prolonged hydrogen secretion and elevate basal hydrogen levels.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients should fast for 8 to 12 hours prior to the breath test.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Strenuous exercise and cigarette smoking should be avoided on the day of the breath test. Smoking increases breath hydrogen levels and increases gastric transit time. Hyperventilation associated with strenuous exercise decreases breath hydrogen levels.</p><p></p><p>We sample breath hydrogen, carbon dioxide, and methane at baseline and every 15 minutes following administration of test substrate (glucose 75 grams or <a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">lactulose</a> 10 grams). Breath testing should be continued for 120 minutes. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Test interpretation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An absolute increase in hydrogen by ≥20 ppm above baseline within 90 minutes on the <a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">lactulose</a>/glucose breath test is diagnostic of SIBO [<a href="#rid21">21,31</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A methane level ≥10 ppm at any point during the test is diagnostic of intestinal methanogen overgrowth (IMO) [<a href="#rid21">21</a>]. While this was previously considered to be diagnostic of SIBO, the term IMO has been introduced to more accurately describe this condition as methanogens are not "bacteria" but belong to the domain Archaea and may also overgrow in the colon and not just the small intestine [<a href="#rid21">21,33</a>]. <em>Methanobrevibacter smithii</em> appears to be the key methanogen responsible for breath methane production. There has been emerging data on the link between the role of microbial methane production, delayed intestinal transit, and constipation [<a href="#rid34">34,35</a>]. Thirty-six to 50 percent of healthy adult subjects are predominantly methane producers [<a href="#rid36">36</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other patterns of elevation may be seen in subgroups of patients. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>High baseline hydrogen ≥20 ppm may be due to lack of adherence to the test protocol for dietary restriction or fasting or may represent a variant of SIBO. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Low fixed hydrogen and no methane production may be due to hydrogen sulfide producing bacteria. However, further studies are needed to clarify the significance.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Constipation is associated with elevated levels of breath methane.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Test performance</strong> – There are several limitations to breath tests as diagnostic test for SIBO. Rapid delivery of the test substrate to the colon (eg, in patients with short bowel syndrome) may lead to false-positive results [<a href="#rid37">37</a>], while gastrointestinal disorders where gastric emptying is delayed may cause a false-negative test [<a href="#rid38">38</a>]. In general, the sensitivity and specificity of the breath test are low, and there is a poor correlation between the breath test and the small bowel aspiration and culture method. In a systematic review that included 14 studies in which SIBO diagnosis was achieved by <a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">lactulose</a>/glucose breath test in comparison to small bowel aspirate culture, the glucose breath test had a pooled sensitivity of 54 percent (95% CI 48.2–60.7 percent), and a pooled specificity of 83 percent (95% CI 79.1–86.9) [<a href="#rid39">39</a>]. The lactulose breath test had a pooled sensitivity of 42 percent (95% CI 31.6–53.0), and the pooled specificity was 71 percent (95% CI 61.9–78.4). However, these studies had several limitations including heterogeneity in patient populations, small sample sizes, and variable cutoffs to define a positive test. (See  <a class="medical medical_review" href="/d/html/4770.html" rel="external">"Pathophysiology of short bowel syndrome", section on 'Small intestine length'</a>.)</p><p></p><p class="headingAnchor" id="H894085110"><span class="h2">Small bowl aspirate culture</span><span class="headingEndMark"> — </span>A bacterial concentration of &gt;10<sup>3</sup> colony forming units/mL of duodenal aspirate is diagnostic of SIBO [<a href="#rid6">6,21,40</a>]. Patients may have multiple organisms in varying concentrations. The most common organisms include <em>Escherichia coli</em> and <em>Klebsiella </em>[<a href="#rid12">12</a>]. Other common Gram-negative flora are <em>Proteus, Acinetobacter, Enterobacter, Citrobacter, Neisseria, Bacteroides, </em>and <em>Clostridia,</em> while predominant isolated Gram-positive flora may include <em>Streptococcus, Staphylococcus, Enterococcus, Micrococcus, Lactobacillus, Corynebacterium, Fusobacterium, </em>and<em> Peptostreptococcus</em>. There may be a mix of Gram-positive and Gram-negative populations, as well as aerobic and anaerobic bacteria [<a href="#rid41">41,42</a>].</p><p>Duodenal aspirate is obtained during upper gastrointestinal endoscopy by placing a sterile catheter through a sterile overtube in the suction port of an endoscope or by fluoroscopy. Aspirates should be transferred to an anaerobic transport vial immediately, and contents should be cultured for the growth of aerobic and anaerobic organisms [<a href="#rid43">43</a>]. </p><p>Although small bowel aspirate cultures have been considered the reference standard for the diagnosis of SIBO, the process of obtaining small bowel aspirate is invasive and the results are poorly reproducible [<a href="#rid44">44</a>]. Culture of anaerobic organisms requires careful microbiologic technique, despite which only approximately 40 percent of the total gut flora can be identified using conventional culture methods [<a href="#rid23">23</a>]. Bacterial overgrowth may be patchy, confined to the distal small intestine (eg, early SIBO), or located in relatively inaccessible sites (eg, blind loop), leading to false-negative results [<a href="#rid45">45</a>]. False-positive cultures can result from contamination with oropharyngeal flora during specimen collection. Historically, SIBO was described in patients with post-surgical anatomy such as stagnant loop syndrome. In these patients the aspirates were obtained from the jejunum and the presence of ≥10<sup>5</sup> colony forming units/mL of colonic-type bacteria in the culture were considered positive for diagnosing SIBO. A lower cut-off of ≥10<sup>3</sup> colony forming units/mL of bacteria is presently recommended for diagnosing SIBO. The lower threshold may be more relevant as most endoscopists aspirate luminal fluid from the duodenum (using a standard upper endoscope), where the bacterial counts are expected to be much lower than in the jejunum.</p><p class="headingAnchor" id="H1781534928"><span class="h2">Investigational methods</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Molecular techniques – </strong>Culture-based methods have clear limitations, and it is now understood that a significant portion (approximately 80 percent) of the microbiota cannot be cultured [<a href="#rid46">46</a>]. Quantitative polymerase chain reaction (qPCR) approach, which focuses on targeting the 16S ribosomal ribonucleic acid (16S rRNA) gene from domain bacteria and the human beta-actin gene, can be successfully employed to measure the bacterial load in the duodenal mucosa of patients with different gastrointestinal disorders [<a href="#rid47">47</a>]. Thus, molecular techniques could offer a cost- and time-effective method of diagnosing SIBO. However, simplification and automation of these molecular techniques for diagnosing SIBO will be necessary to fully utilize their potential in routine clinical settings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gas sensing capsule –</strong> A gas-sensing capsule, which can measure luminal gases (hydrogen and carbon dioxide) after ingestion of a carbohydrate meal as it transits through the lumen of the small bowel, is under development [<a href="#rid48">48</a>]. </p><p></p><p class="headingAnchor" id="H19806954"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of diarrhea due to SIBO includes other causes of chronic diarrhea. This is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings", section on 'Initial evaluation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Celiac disease</strong> – Patients with celiac disease and SIBO may have similar symptoms, elevation in fecal fat, and villous blunting on small bowel biopsy. However, patients with celiac disease have histopathological features on duodenal biopsy and positive celiac serologies. (See  <a class="medical medical_review" href="/d/html/4771.html" rel="external">"Diagnosis of celiac disease in adults", section on 'Serologic evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Crohn disease</strong> – Patchy enteritis in patients with severe SIBO can mimic Crohn disease. Characteristic features of Crohn disease including the presence of perianal disease (fissures, fistulas), chronic transmural inflammation and granulomas on biopsy are absent in SIBO. (See  <a class="medical medical_review" href="/d/html/4067.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults", section on 'Differential diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Irritable bowel syndrome</strong> – Patients with SIBO and irritable bowel syndrome (IBS) may have both diarrhea and constipation [<a href="#rid31">31,49</a>]. IBS is a functional syndrome that is predominantly characterized by recurrent chronic abdominal pain. The abdominal pain in IBS, unlike SIBO, is related to defecation and is associated with a change in frequency or form (appearance) of stool. (See  <a class="medical medical_review" href="/d/html/2629.html" rel="external">"Pathophysiology of irritable bowel syndrome", section on 'Bacterial overgrowth'</a>.)</p><p></p><p class="bulletIndent1">However, it appears that a proportion of patients with IBS [<a href="#rid50">50</a>], celiac disease [<a href="#rid51">51</a>], and Crohn disease [<a href="#rid52">52</a>] have SIBO.</p><p></p><p class="headingAnchor" id="H450869785"><span class="h1">EVALUATION TO DETERMINE THE ETIOLOGY</span><span class="headingEndMark"> — </span>Most patients with established SIBO have a known underlying condition  (<a class="graphic graphic_table graphicRef81285" href="/d/graphic/81285.html" rel="external">table 1</a>). In patients without risk factors for SIBO, we perform an upper endoscopy and colonoscopy to rule out predisposing conditions (eg, atrophic gastritis and Crohn disease). If endoscopic evaluation is unrevealing, we perform imaging of the small bowel to evaluate for partial obstruction, dilation, inflammation, diverticula, or a fistula. We perform a magnetic resonance enterography as it has the advantage of avoiding radiation exposure and has a high sensitivity for detecting small bowel strictures but is expensive. (See  <a class="medical medical_review" href="/d/html/4070.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults", section on 'Imaging'</a>.) </p><p>SIBO may also be associated with a small intestinal motility disorder, cirrhosis, end-stage kidney disease, chronic pancreatitis, and immunodeficiency states. Additional testing for these conditions should be performed in patients with a history or physical examination findings suggestive of these disorders [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/2639.html" rel="external">"Chronic intestinal pseudo-obstruction: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/3928.html" rel="external">"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults"</a>.)</p><p class="headingAnchor" id="H3450719426"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/119548.html" rel="external">"Society guideline links: Small intestinal bacterial overgrowth"</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Small intestinal bacterial overgrowth (SIBO) is a condition in which the small bowel is colonized by excessive aerobic and anaerobic microbes that are normally present in the colon. The incidence of SIBO increases with age. Several disorders predispose to SIBO by altering mucosal defenses  (<a class="graphic graphic_table graphicRef81285" href="/d/graphic/81285.html" rel="external">table 1</a>). In many cases, patients have more than one predisposing cause. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>SIBO can cause maldigestion in the intestinal lumen or malabsorption at the level of the intestinal microvillus membrane due to enterocyte damage. Bacterial overgrowth can also alter small bowel motility. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The majority of patients with SIBO present with bloating, flatulence, abdominal discomfort, or watery diarrhea. Steatorrhea with greasy or bulky stools is rare and usually occurs in patients with altered anatomy (eg, blind loop syndrome). Children can present with failure to gain weight. In severe cases, patients have weight loss due to diarrhea or poor oral intake. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory abnormalities are usually seen in patients with SIBO that is severe or that occurs in association with an anatomic abnormality. Laboratory findings include macrocytic anemia, B12 deficiency, and the presence of fecal fat. Patients may also have low levels of thiamine and niacin and elevated serum folate and vitamin K levels. In rare cases, patients have microcytic anemia or hypoalbuminemia. (See <a class="local">'Laboratory findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The endoscopic appearance and histopathology of the small intestine and colon is normal in most patients with SIBO. Endoscopic findings of enteritis associated with severe SIBO are nonspecific and include mucosal edema, loss of normal vascular pattern, patchy erythema, friability, and ulceration. Histopathological findings associated with SIBO include villous blunting, cryptitis, intraepithelial lymphocytosis, and eosinophilia. (See <a class="local">'Endoscopy findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis of SIBO should be suspected in patients with bloating, flatulence, abdominal discomfort, or diarrhea, and is established with a positive carbohydrate breath test or duodenal aspirate culture. We perform a carbohydrate breath test to diagnose SIBO as it is simple, non-invasive, and widely available. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A bacterial concentration of &gt;10<sup>3</sup> colony forming units/mL of duodenal aspirate is diagnostic of SIBO. However, the test requires an upper endoscopy to obtain an aspirate and the results are poorly reproducible. (See <a class="local">'Small bowl aspirate culture'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carbohydrate breath tests are easy to perform, noninvasive, and inexpensive. The <a class="drug drug_general" data-topicid="9543" href="/d/drug information/9543.html" rel="external">lactulose</a>/glucose breath test is diagnostic of SIBO if there is an absolute increase in hydrogen by ≥20 ppm above baseline within 90 minutes. A methane level ≥10 ppm, regardless of the time during the breath test, can identify intestinal methanogen overgrowth (associated with a constipation phenotype).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some patients with established SIBO have a known underlying condition  (<a class="graphic graphic_table graphicRef81285" href="/d/graphic/81285.html" rel="external">table 1</a>). However, additional tests should be performed if the underlying etiology is unknown, and the patient is refractory to treatment. An upper endoscopy and colonoscopy should also be performed to rule out predisposing conditions (eg, atrophic gastritis and Crohn disease). In patients without a clear underlying predisposing cause, imaging of the small intestine (eg, small bowel follow-through, computed tomography/magnetic resonance enterography) should be performed to rule out an underlying anatomic cause of SIBO. (See <a class="local">'Evaluation to determine the etiology'</a> above.)</p><p></p><p class="headingAnchor" id="H43216237"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate would like to acknowledge Jon Vanderhoof, MD, Rosemary Pauley-Hunter, NP-C, and Mark Pimentel, MD, FRCP(C), who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69:1035S.</a></li><li><a class="nounderline abstract_t">Choung RS, Ruff KC, Malhotra A, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011; 33:1059.</a></li><li><a class="nounderline abstract_t">Pimentel M. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1. Am J Gastroenterol 2010; 105:718.</a></li><li><a class="nounderline abstract_t">Vantrappen G, Janssens J, Hellemans J, Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59:1158.</a></li><li><a class="nounderline abstract_t">Shah ED, Basseri RJ, Chong K, Pimentel M. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 2010; 55:2441.</a></li><li><a class="nounderline abstract_t">Posserud I, Stotzer PO, Björnsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56:802.</a></li><li><a class="nounderline abstract_t">Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, et al. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012; 57:1321.</a></li><li><a class="nounderline abstract_t">Kim G, Morales W, Funari V, et al. Duodenal Aeromonas SPP Are Increased in Number in a Rat Model of Post-Infectious IBS: Translation of Data From Deep Sequencing of the Microbiome in Humans With IBS. Gastroenterology 2013; 144:S542.</a></li><li><a class="nounderline abstract_t">Giamarellos-Bourboulis E, Tang J, Pyleris E, et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 2015; 50:1076.</a></li><li><a class="nounderline abstract_t">Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16:2978.</a></li><li><a class="nounderline abstract_t">Jones RM, Neish AS. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol 2011; 13:670.</a></li><li><a class="nounderline abstract_t">Leite G, Rezaie A, Mathur R, et al. Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing. Clin Gastroenterol Hepatol 2023.</a></li><li><a class="nounderline abstract_t">Kirsch M. Bacterial overgrowth. Am J Gastroenterol 1990; 85:231.</a></li><li><a class="nounderline abstract_t">Justus PG, Fernandez A, Martin JL, et al. Altered myoelectric activity in the experimental blind loop syndrome. J Clin Invest 1983; 72:1064.</a></li><li><a class="nounderline abstract_t">Pai RK. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Semin Diagn Pathol 2014; 31:124.</a></li><li><a class="nounderline abstract_t">Shindo K, Machida M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology 1998; 45:1643.</a></li><li><a class="nounderline abstract_t">Donaldson RM Jr. Role of enteric microorganisms in malabsorption. Fed Proc 1967; 26:1426.</a></li><li><a class="nounderline abstract_t">Sherman P, Lichtman S. Small bowel bacterial overgrowth syndrome. Dig Dis 1987; 5:157.</a></li><li><a class="nounderline abstract_t">Su J, Smith MB, Rerknimitr R, Morrow D. Small intestine bacterial overgrowth presenting as protein-losing enteropathy. Dig Dis Sci 1998; 43:679.</a></li><li><a class="nounderline abstract_t">Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microb Pathog 1997; 22:285.</a></li><li><a class="nounderline abstract_t">Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol 2020; 115:165.</a></li><li><a class="nounderline abstract_t">Shah A, Ghoshal UC, Holtmann GJ. Unravelling the controversy with small intestinal bacterial overgrowth. Curr Opin Gastroenterol 2023; 39:211.</a></li><li><a class="nounderline abstract_t">Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am 2010; 24:943.</a></li><li><a class="nounderline abstract_t">de Boissieu D, Chaussain M, Badoual J, et al. Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr 1996; 128:203.</a></li><li><a class="nounderline abstract_t">Collins BS, Lin HC. Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation. Dig Dis Sci 2010; 55:124.</a></li><li><a class="nounderline abstract_t">Taylor SF, Sondheimer JM, Sokol RJ, et al. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr 1991; 119:24.</a></li><li><a class="nounderline abstract_t">Tabaqchali S, Pallis C. Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis. Gut 1970; 11:1024.</a></li><li><a class="nounderline abstract_t">Giannella RA, Toskes PP. Gastrointestinal bleeding and iron absorption in the experimental blind loop syndrome. Am J Clin Nutr 1976; 29:754.</a></li><li><a class="nounderline abstract_t">Klaus J, Spaniol U, Adler G, et al. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease. BMC Gastroenterol 2009; 9:61.</a></li><li><a class="nounderline abstract_t">Lappinga PJ, Abraham SC, Murray JA, et al. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med 2010; 134:264.</a></li><li><a class="nounderline abstract_t">Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol 2017; 112:775.</a></li><li><a class="nounderline abstract_t">Cangemi DJ, Lacy BE, Wise J. Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates. Dig Dis Sci 2021; 66:2042.</a></li><li><a class="nounderline abstract_t">Ghoshal UC, Sachdeva S, Ghoshal U, et al. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association. Indian J Gastroenterol 2022; 41:483.</a></li><li><a class="nounderline abstract_t">Kunkel D, Basseri RJ, Makhani MD, et al. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci 2011; 56:1612.</a></li><li><a class="nounderline abstract_t">Gandhi A, Shah A, Jones MP, et al. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis. Gut Microbes 2021; 13:1933313.</a></li><li><a class="nounderline abstract_t">Levitt MD, Furne JK, Kuskowski M, Ruddy J. Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements. Clin Gastroenterol Hepatol 2006; 4:123.</a></li><li><a class="nounderline abstract_t">Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91:1795.</a></li><li class="breakAll">Eslick GD. Chapter 6 - Clinical Conditions Associated With Bacterial Overgrowth. In: Gastrointestinal Diseases and their Associated Infections, Elsevier, 2019. p.67.</li><li><a class="nounderline abstract_t">Losurdo G, Leandro G, Ierardi E, et al. Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis. J Neurogastroenterol Motil 2020; 26:16.</a></li><li><a class="nounderline abstract_t">Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008; 53:1443.</a></li><li><a class="nounderline abstract_t">Erdogan A, Rao SS, Gulley D, et al. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil 2015; 27:481.</a></li><li><a class="nounderline abstract_t">Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999; 94:1327.</a></li><li><a class="nounderline abstract_t">Bardhan PK, Gyr K, Beglinger C, et al. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol 1992; 27:253.</a></li><li class="breakAll">Shanab AA, Quera RM, Quigley EMM. Small intestinal bacterial overgrowth. In: Textbook of Clinical Gastroenterology and Hepatology, 2nd ed, Hawkey CJ, Bosch J, Richter JE, et al (Eds), Wiley-Blackwell, Malden, MA 2012.</li><li><a class="nounderline abstract_t">Fan X, Sellin JH. Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther 2009; 29:1069.</a></li><li><a class="nounderline abstract_t">Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635.</a></li><li><a class="nounderline abstract_t">Shah A, Talley NJ, Koloski N, et al. Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Aliment Pharmacol Ther 2020; 52:155.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Berean KJ, Ha N, et al. A human pilot of ingestible eletronic capsules capable of sending different gases in the gut. Nature Electronics 2018; 1:79.</a></li><li><a class="nounderline abstract_t">Ratuapli SK, Ellington TG, O'Neill MT, et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol 2012; 107:730.</a></li><li><a class="nounderline abstract_t">Shah A, Talley NJ, Jones M, et al. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Am J Gastroenterol 2020; 115:190.</a></li><li><a class="nounderline abstract_t">Shah A, Thite P, Hansen T, et al. Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022; 37:1844.</a></li><li><a class="nounderline abstract_t">Shah A, Morrison M, Burger D, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther 2019; 49:624.</a></li></ol></div><div id="topicVersionRevision">Topic 4776 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10232646" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Developmental microbial ecology of the neonatal gastrointestinal tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21395630" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20372119" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/864008" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20467896" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Abnormal breath testing in IBS: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17148502" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22262197" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Duodenal Aeromonas SPP Are Increased in Number in a Rat Model of Post-Infectious IBS: Translation of Data From Deep Sequencing of the Microbiome in Humans With IBS</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25865706" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20572300" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Small intestinal bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21352463" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Recognition of bacterial pathogens and mucosal immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37315761" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2178395" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6350361" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Altered myoelectric activity in the experimental blind loop syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24815938" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A practical approach to small bowel biopsy interpretation: celiac disease and its mimics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9840121" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6051324" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Role of enteric microorganisms in malabsorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3311488" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Small bowel bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9539668" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Small intestine bacterial overgrowth presenting as protein-losing enteropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9160298" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32023228" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37144539" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Unravelling the controversy with small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20937459" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636812" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19888655" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1676730" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Noninfectious colitis associated with short gut syndrome in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4252216" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1084685" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Gastrointestinal bleeding and iron absorption in the experimental blind loop syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19643023" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20121616" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28323273" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32681227" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36214973" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21286935" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Methane on breath testing is associated with constipation: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34190027" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16469670" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8792701" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The lactulose breath hydrogen test and small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8792701" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The lactulose breath hydrogen test and small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31743632" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review With Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17990113" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A systematic review of diagnostic tests for small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25600077" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10235214" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1502491" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1502491" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19222407" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Review article: Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15831718" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Diversity of the human intestinal microbial flora.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32412673" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A human pilot of ingestible eletronic capsules capable of sending different gases in the gut</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22334250" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31913194" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35734803" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30735254" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
